Phase I study of preoperative intensity modulated radiation therapy (IMRT) with incorporated boost and oral capecitabine in locally advanced rectal cancer
Phase of Trial: Phase I
Latest Information Update: 16 Feb 2010
At a glance
- Drugs Capecitabine (Primary)
- Indications Rectal cancer
- Focus Adverse reactions
- 16 Feb 2010 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 16 Feb 2010 Actual end date (Feb 2007) added as reported by ClinicalTrials.gov.
- 22 Aug 2006 Status change